
Dr. Mostashari: The Aledade MSSP ACOs Are Thriving
Farzad Mostashari discusses the success of the Aledade-facilitated ACOs in the MSSP
Farzad Mostashari discusses the success of the Aledade-facilitated ACOs in the MSSP
Despite achieving statistically signficant improvement in progression-free survival in North American and European patients, Summit’s drug ivonescimab fell short of the other Phase 3 goal measuring overall survival. It’s the first Phase 3 readout for an emerging class of bispecific antibodies that treat cancer by blocking two targets, PD-1 and VEGF. The post Summit Lung…
Cada año, durante nuestras vacaciones familiares en Cape Cod, disfrutamos de todos los placeres clásicos del verano: escalar dunas, caminar por la playa, observar focas, comer ostras y leer los libros que nos habíamos propuesto durante todo el año. También hacer compras. Mi nieto quería unos juguetes pequeños. Mi hija aprovechó para llevarse varios rompecabezas…
En los últimos años, en la capital de Michigan y sus alrededores, Rebecca Kasen ha visto y oído cosas que nunca habría imaginado. “Estamos viviendo un momento muy extraño”, reflexionó Kasen, directora ejecutiva del Women’s Center of Greater Lansing. Una madrugada de noviembre, una cámara de vigilancia del Women’s Center captó a un grupo de…
This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.
This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.
This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.
This data note reviews trends in homelessness and characteristics of people who are homeless using data from HUD’s Point-in-Time (PIT) count of sheltered and unsheltered people experiencing homelessness.
Keith Roberts, a litigation attorney on regulatory matters with New Jersey-based law firm Brach Eichler, shares his perspective on the Trump Administration’s AI Action Plan
Initiative developed to provide a protected environment for Vermont researchers to access and analyze clinical data